Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03676816 · ClinicalTrials.gov registry record · NA
Self Sampling for Rapid Turnaround Testing in the Emergency Department
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 533
- Enrollment target
NCT03676816 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 533 participants.
The verdict
NCT03676816, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 533 participants
- Enrollment target
Study Summary
Consenting adult female patient felt by the provider to require gonorrhea/chlamydia endocervical testing will be asked to provide an additional self sample specimen. The specimen will be sent to the laboratory using conventional diagnostic test for gonorrhea/chlamydia.
Interventions
- PROCEDURE vaginal self sampling
- PROCEDURE provider-performed endocervical sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 533 participants |
| Start Date | 2018-09-17 |
| Est. Completion | 2020-06-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03676816
The ClinicalTrials.gov registry entry for NCT03676816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 533 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which vaginal self sampling is the first listed.
NCT03676816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03676816 about?
NCT03676816 is a clinical study titled "Self Sampling for Rapid Turnaround Testing in the Emergency Department". Consenting adult female patient felt by the provider to require gonorrhea/chlamydia endocervical testing will be asked to provide an additional self sample specimen. The specimen will be sent to the laboratory using conventional diagnostic test for gonorrhea/chlamydia.
What is the current status of trial NCT03676816?
This trial is currently completed. It is a NA study. The enrollment target is 533 participants. The study started on 2018-09-17. Estimated completion is 2020-06-09.
What interventions are being tested in trial NCT03676816?
The interventions under investigation include: vaginal self sampling (PROCEDURE), provider-performed endocervical sampling (PROCEDURE).
Who is sponsoring clinical trial NCT03676816?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.